Czibere Akos bought AKTS
September 23, 2026 · Form 4 insider transaction
Czibere Akos bought 12,500 shares of Aktis Oncology, Inc. at $4.95 per share, a transaction worth $61.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$4.95
Total value
$61.9K
InsiderCzibere Akos
RoleOfficer
CompanyAktis Oncology, Inc. (AKTS)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 23, 2026
Filing dateSeptember 24, 2026
Shares owned after12,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2026.